Professor, Virology and Microbiology, Baylor College of Medicine

Infectious Disease

Dr. Wendy A. Keitel, MD

Wendy Keitel practices Infectious Disease. Dr. Wendy A. Keitel is a published physician as well. She has 101 publications published. The latest was: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.

Publications

Humoral and Cell Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.
Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1)...
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons â¥18 Years Old.
Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant.
Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection...
Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial.
Prenatal passive transfer of maternal immunity in Asian elephants (Elephas maximus).
Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster.
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters.
Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes.
Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women.
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
Safety and immunogenicity of a candidate parvovirus B19 vaccine.
Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults.
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized cli...
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
Rapid licensure of a new, inactivated influenza vaccine in the United States.
Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus.
Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Progress in the Diagnosis, Prevention, and Treatment of Pertussis.
Multiple Epstein-Barr virus infections in healthy individuals.
The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study.
Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria.
Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination.
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
Domain specificity of the human antibody response to Bacillus anthracis protective antigen.
Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.
Paratope diversity in the human antibody response to Bacillus anthracis protective antigen.
Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7".
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Tri...
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
Efficacy of an acellular pertussis vaccine among adolescents and adults.
Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.
Cellular and acellular pertussis vaccines in adults.
Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper e...
Severe paroxysmal coughing and pleuritic pain in an adult.
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
Improvement of inactivated influenza virus vaccines.
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
Acellular pertussis vaccines in adults.
A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization.
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
Diurnal variation in responses to influenza vaccine.
Pertussis in adolescents and adults: time to reimmunize?
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.
Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines.
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
Influenza: its control in persons and populations.
Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria ...
[The High Priest of gout - Sir Alfred Baring Garrod (1819-1907)].
[The magician from Paris (Jean Martin Charcot 1825-1893). II. Artist and man with a contradiction].
[The Paris magician (Jean Martin Charcot 1825-1893 1. Multiple scientific talents].
[Hans Reiter and the oculo-urethro-synovial syndrome. Epilogue and legacy].
Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised).
[Hans Reiter and the oculo-urethro-synovial syndrome. 2. Reiter and "his" disease -- the hunt for the chimera].
[Hans Reiter and the oculo-urethro-synovial syndrome. 3. The unknown Hans Reiter, scientist and national socialism propagandist].
[Hans Reiger and oculo-urethro-synovial syndrome. 1. History of the disease].
[The Greek and the Turk: Benediktos Adamantiades (1875-1965) and HulÃƒÂ»si BehÃƒÂ§et (1889-1948)].
[The promising student Pierre Marie (1853-1940)].
[A victim of Stalin''s politics? Wladimir Michailowitsch Bechterew (1857-1927)].
Current epidemiological data from the German Registry of Adamantiades-BehÃƒÂ§et's disease.
[A.I. Nesterow (1895-1979) and Russian rheumatology].
[The indefatigable Hans Tichy (1888-1970)].
[Guillaume de Baillou (1538-1616)--the father of "rheumatism"?].
Prevalence of Adamantiades-BehÃƒÂ§et's disease in Germany and the municipality of Berlin: results of a nationwide survey.
[Jean-Baptiste Bouillaud (1796-1881) -- rheumatologist, cardiologist and more].
[A man with his own opinions--Paul Schober (1865-1943)].
[Johann Lukas SchÃƒÂ¶nlein (1793-1864). The degraded honorary citizen].
[The pathologists: Aschoff, Klinge and GrÃƒÂ¤ff].
[Influence of adjuvant with joint and skin antigens on adjuvants arthritis in rats, mice and hamsters].
[Antigen analysis using rabbit antiserums against joint antigens of man and rat].
[Influence of different antigens on macrophage migration following injection of complete Freund''s adjuvant].
[Rarabiosis studies in adjuvant arthritis (preliminary results)].
[Comparative histology of adjuvant arthritis in rats, mice and hamsters].
[Comparative studies on efficiency of pelotherapy in rheumatology].
[Expert testimony of rheumatic diseases].
[Diagnostic procedure in rheumatic diseases].
[Tumor contact preprations as antigen substrate for immunofluorescent demonstration of antinuclear antibodies].
[Immunosuppressive therapy of the rheumatoid arthritis. mutual evaluation of establishments within the frame of the AFG rheumatology in jena].
[Clinical aspects of gout].

Schools

Duke University

Doctors Specialties

Internal Medicine
Infectious Disease

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Ana Blackmon, MD This Doctor is OpenDoctor Recommended.
	Dr. Johanna L. Chan, MD
	Dr. Roy F. Chemaly, MD This Doctor is OpenDoctor Recommended.
	Dr. Hoonmo L. Koo, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert L. Atmar, MD This Doctor is OpenDoctor Recommended.